Both in Lab Analytical Instruments
EyePoint vs Nautilus Biotechnolgy
Over the past year EYPT returned −97.2% and NAUT returned +47.6%; their daily moves had a correlation of -0.09.
EYPT −97.2% NAUT +47.6%Growth of $1, one year, split-adjusted
| Metric | EYPT | NAUT |
|---|---|---|
| Price | $0.3484 | $2.73 |
| Market cap | $30.0M | $347.7M |
| Today | −8.32% | −13.06% |
| 1 month | −89.2% | +73.9% |
| 6 months | −97.4% | +1.1% |
| Year to date | −98.1% | +40.0% |
| 1 year | −97.0% | +93.6% |
| Revenue growth (YoY) | −90.5% | — |
| Gross margin | 100.0% | 89.7% |
| Net margin | −18633.1% | −6682.1% |
| P/E (TTM) | — | — |
| Price / sales | 10.8× | 820.1× |
| Net cash | $180.5M | $86.6M |
| Dividend yield | — | — |
| Volatility (60d) | 453.8% | 152.3% |
| Short % of float | 25.5% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).